LAS VEGAS, Dec. 16, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), an emerging biotechnology company focused on developing cell-based therapies for diabetes ...
Both platforms are backed by over 50 peer-reviewed publications representing decades of development. The addressable markets span multiple areas: Alzheimer's disease ($32.8 billion by 2033), ...
Global capital is officially rotating into "Longevity Infrastructure" which is now valued at a massive $27 trillion by 2030 ...
NEW YORK, USA, August 21, 2023/EINPresswire.com/ -- Altucell Therapeutics is making monumental advancements in the realm of diabetes care. The company remains at the ...
The PV industry is experiencing rapid technological evolution. Emerging cell technologies are driving deeper synergy between PV modules and encapsulation materials. While different technical routes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results